AMANTADINE HYDROCHLORIDE

AMANTADINE HYDROCHLORIDE was reported 4931 times

AMANTADINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OPSOCLONUS 4 0.1739
1 CEREBRAL HYPOPERFUSION 63 0.1352
2 DYSKINESIA HYPERPYREXIA SYNDROME 6 0.1277
3 BINOCULAR EYE MOVEMENT DISORDER 30 0.1042
4 CEREBELLAR STROKE 30 0.0767
5 PARKINSONISM HYPERPYREXIA SYNDROME 11 0.0615
6 CAMPTOCORMIA 10 0.0417
7 DOPAMINE DYSREGULATION SYNDROME 18 0.0404
8 DRUG THERAPEUTIC INCOMPATIBILITY 6 0.0390
9 PATHOLOGICAL GAMBLING 61 0.0367
10 PROGRESSIVE SUPRANUCLEAR PALSY 6 0.0299
11 CATHETER SITE NODULE 5 0.0262
12 PARKINSON'S DISEASE 59 0.0232
13 CATHETER SITE INDURATION 4 0.0207
14 DELUSION OF GRANDEUR 9 0.0200
15 HYPORESPONSIVE TO STIMULI 21 0.0179
16 CORNEAL OEDEMA 40 0.0178
17 JEALOUS DELUSION 5 0.0177
18 CORNEA VERTICILLATA 5 0.0164
19 HYPERSEXUALITY 29 0.0159
20 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 4 0.0158
21 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 6 0.0149
22 HALLUCINATION, OLFACTORY 6 0.0138
23 AKINESIA 27 0.0130
24 ON AND OFF PHENOMENON 72 0.0130
25 STOMA SITE EXTRAVASATION 5 0.0130
26 STOMA SITE HYPERGRANULATION 8 0.0127
27 DUPLICATE THERAPY ERROR 4 0.0125
28 LIVEDO RETICULARIS 26 0.0124
29 MASKED FACIES 5 0.0123
30 PLEUROTHOTONUS 10 0.0111
31 HALLUCINATION, TACTILE 7 0.0105
32 SLEEP ATTACKS 5 0.0105
33 RENAL VEIN THROMBOSIS 7 0.0104
34 GAMBLING 12 0.0103
35 ACUTE PSYCHOSIS 25 0.0101
36 SLOW RESPONSE TO STIMULI 13 0.0100
37 AORTIC VALVE SCLEROSIS 7 0.0095
38 RELAPSING-REMITTING MULTIPLE SCLEROSIS 8 0.0093
39 REFLEXES ABNORMAL 6 0.0092
40 DEPERSONALISATION 7 0.0084
41 HALLUCINATIONS, MIXED 35 0.0083
42 IMPULSE-CONTROL DISORDER 17 0.0083
43 PRINZMETAL ANGINA 8 0.0080
44 COGWHEEL RIGIDITY 8 0.0076
45 BRADYKINESIA 41 0.0069
46 PROGRESSIVE MULTIPLE SCLEROSIS 8 0.0069
47 DEEP BRAIN STIMULATION 4 0.0066
48 MYOCLONUS 78 0.0065
49 SUDDEN ONSET OF SLEEP 9 0.0065
50 HALLUCINATION, VISUAL 136 0.0064
51 AORTIC VALVE INCOMPETENCE 26 0.0061
52 COMPULSIONS 4 0.0060
53 RENAL TUBULAR INJURY 7 0.0058
54 NEUROGENIC BLADDER 12 0.0057
55 FREEZING PHENOMENON 21 0.0057
56 NEUROLEPTIC MALIGNANT SYNDROME 67 0.0056
57 DYSLALIA 4 0.0055
58 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 8 0.0055
59 CORNEAL DEPOSITS 4 0.0054
60 CATHETER SITE SWELLING 5 0.0053
61 STEREOTYPY 5 0.0053
62 CHOREA 9 0.0052
63 BEZOAR 7 0.0051
64 DYSKINESIA 204 0.0050
65 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 4 0.0049
66 JUDGEMENT IMPAIRED 7 0.0048
67 OBSESSIVE-COMPULSIVE DISORDER 38 0.0047
68 POSTURE ABNORMAL 15 0.0046
69 LIBIDO INCREASED 9 0.0044
70 COMPULSIVE SHOPPING 9 0.0044
71 TONGUE BITING 9 0.0044
72 EXTENSOR PLANTAR RESPONSE 4 0.0043
73 RAYNAUD'S PHENOMENON 4 0.0043
74 CEREBRAL ATROPHY 17 0.0043
75 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 8 0.0043
76 DELUSION 66 0.0042
77 ILLUSION 7 0.0042
78 PARKINSONISM 41 0.0042
79 CEREBELLAR ATAXIA 4 0.0042
80 CORNEAL DISORDER 9 0.0041
81 STOMA SITE PAIN 6 0.0041
82 INFUSION SITE INDURATION 6 0.0040
83 LUPUS VULGARIS 5 0.0040
84 FRUSTRATION TOLERANCE DECREASED 32 0.0040
85 BAND SENSATION 5 0.0039
86 MUSCLE RIGIDITY 47 0.0039
87 BRUGADA SYNDROME 4 0.0039
88 AUTONOMIC NERVOUS SYSTEM IMBALANCE 11 0.0038
89 DISINHIBITION 6 0.0037
90 BINGE EATING 4 0.0037
91 MICTURITION URGENCY 42 0.0037
92 MITRAL VALVE INCOMPETENCE 41 0.0036
93 PERSECUTORY DELUSION 9 0.0036
94 VENTRICULAR HYPERTROPHY 9 0.0036
95 SLEEP TALKING 6 0.0035
96 HYPERPHAGIA 14 0.0035
97 BLOOD AMYLASE INCREASED 6 0.0035
98 ELECTROENCEPHALOGRAM ABNORMAL 11 0.0035
99 HALLUCINATION 260 0.0034
100 INFUSION SITE INFECTION 8 0.0034
101 INJECTION SITE NECROSIS 7 0.0034
102 DILATATION ATRIAL 4 0.0034
103 PULMONARY VALVE INCOMPETENCE 5 0.0034
104 VESTIBULAR DISORDER 4 0.0033
105 INFUSION SITE WARMTH 4 0.0033
106 SPEECH DISORDER 170 0.0032
107 STOMA SITE INFECTION 4 0.0031
108 READING DISORDER 7 0.0031
109 GAZE PALSY 5 0.0029
110 CORNEAL OPACITY 4 0.0029
111 AGORAPHOBIA 4 0.0029
112 IMPAIRED SELF-CARE 6 0.0029
113 MENISCUS LESION 4 0.0029
114 INFUSION SITE DISCHARGE 5 0.0028
115 TORTICOLLIS 6 0.0028
116 PARAPARESIS 5 0.0028
117 NOCTURIA 34 0.0028
118 MULTIPLE SCLEROSIS 132 0.0028
119 DIABETES MELLITUS NON-INSULIN-DEPENDENT 4 0.0027
120 SCLERODERMA 10 0.0027
121 MULTIPLE SCLEROSIS RELAPSE 188 0.0027
122 FAECALOMA 15 0.0027
123 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
124 STOMA SITE ERYTHEMA 5 0.0027
125 CATATONIA 14 0.0027
126 METABOLIC ENCEPHALOPATHY 8 0.0027
127 HALLUCINATION, AUDITORY 42 0.0026
128 INCOHERENT 17 0.0026
129 CONTRAINDICATION TO MEDICAL TREATMENT 4 0.0026
130 BLOOD SODIUM INCREASED 7 0.0026
131 DYSTONIA 49 0.0025
132 TRICUSPID VALVE INCOMPETENCE 20 0.0025
133 LACUNAR INFARCTION 6 0.0025
134 GRAND MAL CONVULSION 23 0.0025
135 SLOW SPEECH 6 0.0025
136 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 25 0.0024
137 FIBULA FRACTURE 7 0.0024
138 DYSARTHRIA 91 0.0024
139 BEHAVIOUR DISORDER 13 0.0024
140 MOTOR DYSFUNCTION 24 0.0024
141 COMMUNICATION DISORDER 9 0.0024
142 INFUSION SITE REACTION 7 0.0023
143 DELIRIUM 81 0.0023
144 DIFFICULTY IN WALKING 8 0.0023
145 FIXED ERUPTION 4 0.0023
146 VENTRICULAR DYSFUNCTION 6 0.0023
147 PUPIL FIXED 4 0.0023
148 PSYCHOTIC DISORDER 68 0.0023
149 CEREBELLAR SYNDROME 5 0.0023
150 WALKING AID USER 15 0.0023
151 MITRAL VALVE DISEASE 4 0.0023
152 WHEELCHAIR USER 10 0.0022
153 AREFLEXIA 6 0.0022
154 TEMPERATURE REGULATION DISORDER 5 0.0022
155 TRIGEMINAL NEURALGIA 9 0.0022
156 GAMBLING DISORDER 6 0.0022
157 DECUBITUS ULCER 18 0.0022
158 CLONUS 6 0.0022
159 STOMA SITE DISCHARGE 6 0.0022
160 ASPIRATION 24 0.0022
161 FEELING COLD 61 0.0022
162 TOXIC ENCEPHALOPATHY 11 0.0022
163 DISORGANISED SPEECH 4 0.0022
164 INJECTION SITE CELLULITIS 4 0.0022
165 BALANCE DISORDER 185 0.0021
166 IMPULSIVE BEHAVIOUR 8 0.0021
167 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 7 0.0021
168 PERONEAL NERVE PALSY 12 0.0021
169 STARING 5 0.0021
170 DYSPHEMIA 9 0.0021
171 PSYCHIATRIC SYMPTOM 15 0.0020
172 ORTHOSTATIC HYPOTENSION 35 0.0020
173 GENERAL SYMPTOM 15 0.0020
174 CATHETER SITE HAEMORRHAGE 5 0.0020
175 KERATITIS 6 0.0020
176 MASTICATION DISORDER 6 0.0020
177 AORTIC ARTERIOSCLEROSIS 5 0.0019
178 PSYCHOTIC SYMPTOM 4 0.0019
179 ATAXIA 23 0.0019
180 CATHETER SITE PAIN 5 0.0019
181 DIPLOPIA 50 0.0019
182 INSULIN RESISTANCE 4 0.0019
183 DEVICE KINK 7 0.0019
184 DILATATION VENTRICULAR 4 0.0019
185 DEVICE CONNECTION ISSUE 4 0.0019
186 HYPERKINESIA 4 0.0019
187 CATHETER SITE ERYTHEMA 4 0.0019
188 IMMOBILE 8 0.0018
189 DYSGRAPHIA 12 0.0018
190 HYPERNATRAEMIA 9 0.0018
191 SENSATION OF HEAVINESS 7 0.0018
192 GASTROINTESTINAL ULCER 4 0.0018
193 DIABETIC COMA 5 0.0018
194 CONVULSION 102 0.0018
195 INFUSION SITE ERYTHEMA 15 0.0018
196 DRUG TOXICITY 24 0.0018
197 OESOPHAGEAL STENOSIS 5 0.0018
198 INFUSION SITE SWELLING 11 0.0017
199 PARANOIA 30 0.0017
200 HYPERTONIC BLADDER 5 0.0017
201 HYPERREFLEXIA 6 0.0017
202 ECONOMIC PROBLEM 26 0.0017
203 COGNITIVE DISORDER 80 0.0017
204 DYSSTASIA 50 0.0017
205 INCONTINENCE 18 0.0017
206 HYPERTHERMIA 13 0.0017
207 DECREASED INTEREST 10 0.0017
208 MENTAL STATUS CHANGES 47 0.0017
209 PNEUMONIA ASPIRATION 42 0.0017
210 URINARY HESITATION 4 0.0017
211 BRUXISM 9 0.0017
212 SEROTONIN SYNDROME 32 0.0017
213 DIABETES INSIPIDUS 4 0.0017
214 NEURALGIA 40 0.0016
215 HYPOMANIA 6 0.0016
216 ENCEPHALOPATHY 40 0.0016
217 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
218 PRESYNCOPE 39 0.0016
219 HYPOKINESIA 23 0.0016
220 EXCORIATION 4 0.0016
221 GAIT DISTURBANCE 298 0.0016
222 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
223 URINARY INCONTINENCE 46 0.0016
224 BLOOD CHLORIDE DECREASED 4 0.0015
225 MUSCLE SPASTICITY 19 0.0015
226 INFUSION SITE HAEMORRHAGE 5 0.0015
227 PEPTIC ULCER 5 0.0015
228 LACERATION 14 0.0015
229 BRONCHOPNEUMONIA 5 0.0015
230 FAECAL INCONTINENCE 7 0.0015
231 ABASIA 36 0.0015
232 CENTRAL NERVOUS SYSTEM LESION 20 0.0015
233 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
234 CAROTID ARTERY STENOSIS 5 0.0014
235 DEPRESSIVE SYMPTOM 5 0.0014
236 TARDIVE DYSKINESIA 40 0.0014
237 SUDDEN DEATH 15 0.0014
238 DIABETIC NEUROPATHY 7 0.0014
239 ABNORMAL BEHAVIOUR 56 0.0014
240 UROSEPSIS 13 0.0014
241 INTERVERTEBRAL DISC DISORDER 6 0.0014
242 VISUAL DISTURBANCE 8 0.0014
243 RETINAL VEIN OCCLUSION 4 0.0014
244 LUNG CANCER METASTATIC 4 0.0014
245 MONOPLEGIA 6 0.0014
246 LUMBAR SPINAL STENOSIS 4 0.0014
247 MAJOR DEPRESSION 10 0.0014
248 TREMOR 226 0.0014
249 CEREBRAL ISCHAEMIA 7 0.0014
250 ILEUS PARALYTIC 6 0.0013
251 URINE ANALYSIS ABNORMAL 4 0.0013
252 BONE MARROW DISORDER 4 0.0013
253 AGITATION 97 0.0013
254 HAEMODIALYSIS 11 0.0013
255 TALIPES 4 0.0013
256 SKIN ABRASION 6 0.0013
257 TEMPERATURE INTOLERANCE 13 0.0013
258 SCREAMING 8 0.0013
259 SPINAL OSTEOARTHRITIS 11 0.0013
260 MOVEMENT DISORDER 40 0.0012
261 STUPOR 4 0.0012
262 HYPERCHOLESTEROLAEMIA 12 0.0012
263 APATHY 18 0.0012
264 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
265 ANGINA UNSTABLE 8 0.0012
266 DEMYELINATION 5 0.0012
267 FALL 405 0.0012
268 SELF-MEDICATION 5 0.0012
269 MANIA 20 0.0012
270 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
271 HYPOTONIA 12 0.0012
272 CORONARY ARTERY STENOSIS 6 0.0012
273 PEMPHIGOID 9 0.0012
274 CLOSTRIDIAL INFECTION 4 0.0012
275 DEMENTIA 33 0.0012
276 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
277 INJECTION SITE HAEMATOMA 17 0.0012
278 EXTRAPYRAMIDAL DISORDER 29 0.0012
279 PERIPHERAL VASCULAR DISORDER 6 0.0012
280 TYPE 1 DIABETES MELLITUS 7 0.0012
281 PRESCRIBED UNDERDOSE 23 0.0012
282 HYPOPNOEA 4 0.0012
283 BEDRIDDEN 15 0.0011
284 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
285 LOGORRHOEA 4 0.0011
286 DIZZINESS POSTURAL 11 0.0011
287 DUODENAL ULCER 8 0.0011
288 NYSTAGMUS 6 0.0011
289 UNRESPONSIVE TO STIMULI 29 0.0011
290 HAEMOLYTIC ANAEMIA 10 0.0011
291 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
292 FACIAL BONES FRACTURE 4 0.0011
293 VISUAL FIELD DEFECT 8 0.0011
294 DRUG EFFECT DELAYED 5 0.0011
295 SPONDYLITIS 4 0.0011
296 RESTLESS LEGS SYNDROME 20 0.0011
297 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
298 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
299 INFUSION SITE PAIN 14 0.0011
300 ALCOHOL USE 4 0.0011
301 SLUGGISHNESS 11 0.0011
302 BLOOD UREA INCREASED 18 0.0011
303 LYMPHOCYTE COUNT DECREASED 19 0.0011
304 FEELING OF DESPAIR 5 0.0011
305 PERFORMANCE STATUS DECREASED 5 0.0011
306 DISORIENTATION 42 0.0011
307 CATHETER SITE INFECTION 4 0.0011
308 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
309 LOSS OF CONTROL OF LEGS 4 0.0011
310 FACE INJURY 4 0.0011
311 DYSPHAGIA 100 0.0011
312 HYPERTONIA 6 0.0010
313 GAIT INABILITY 35 0.0010
314 CYSTITIS 33 0.0010
315 HYPERVENTILATION 6 0.0010
316 ANKLE FRACTURE 16 0.0010
317 BRAIN OEDEMA 13 0.0010
318 EYE MOVEMENT DISORDER 7 0.0010
319 TORSADE DE POINTES 8 0.0010
320 POLYDIPSIA 4 0.0010
321 HYPERSOMNIA 29 0.0010
322 SKIN LACERATION 11 0.0010
323 BLADDER DISORDER 10 0.0010
324 HYPERLIPIDAEMIA 12 0.0010
325 MUSCULAR WEAKNESS 114 0.0010
326 URINARY TRACT INFECTION 171 0.0010
327 SKIN PAPILLOMA 4 0.0010
328 CONFUSIONAL STATE 161 0.0010
329 SENSORY LOSS 8 0.0010
330 DYSPHONIA 58 0.0010
331 ACUTE RESPIRATORY FAILURE 19 0.0010
332 MALNUTRITION 11 0.0010
333 IRON DEFICIENCY ANAEMIA 9 0.0010
334 SPINAL COMPRESSION FRACTURE 8 0.0010
335 AGGRESSION 48 0.0010
336 INTENTIONAL UNDERDOSE 7 0.0010
337 DEPRESSION 218 0.0010
338 SLEEP TERROR 4 0.0009
339 HEAD INJURY 30 0.0009
340 HYPERPYREXIA 4 0.0009
341 BUNDLE BRANCH BLOCK LEFT 4 0.0009
342 EATING DISORDER 20 0.0009
343 MUSCULOSKELETAL STIFFNESS 82 0.0009
344 INFLUENZA LIKE ILLNESS 77 0.0009
345 COORDINATION ABNORMAL 13 0.0009
346 APHASIA 28 0.0009
347 RIB FRACTURE 19 0.0009
348 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
349 FLUSHING 93 0.0009
350 RENAL FAILURE CHRONIC 7 0.0009
351 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
352 DISTURBANCE IN ATTENTION 49 0.0009
353 INTESTINAL ISCHAEMIA 5 0.0009
354 THERAPEUTIC RESPONSE SHORTENED 30 0.0009
355 CONCUSSION 7 0.0009
356 SALIVARY HYPERSECRETION 9 0.0009
357 FEAR 24 0.0009
358 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
359 GRANULOCYTOPENIA 5 0.0009
360 MOBILITY DECREASED 63 0.0009
361 CORONARY ARTERY OCCLUSION 12 0.0009
362 CARDIAC VALVE DISEASE 5 0.0009
363 SENSORY DISTURBANCE 14 0.0009
364 VENTRICULAR EXTRASYSTOLES 9 0.0009
365 POLLAKIURIA 36 0.0009
366 FORMICATION 6 0.0009
367 VASCULITIS 10 0.0009
368 HAEMATOCRIT DECREASED 17 0.0009
369 APPLICATION SITE REACTION 6 0.0009
370 URINE ODOUR ABNORMAL 5 0.0008
371 VENTRICULAR TACHYCARDIA 14 0.0008
372 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
373 GASTRIC ULCER 16 0.0008
374 PARALYSIS 12 0.0008
375 SUBDURAL HAEMATOMA 12 0.0008
376 ODYNOPHAGIA 5 0.0008
377 INCORRECT DOSAGE ADMINISTERED 4 0.0008
378 CARDIOMEGALY 10 0.0008
379 PYELONEPHRITIS 7 0.0008
380 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
381 RENAL FAILURE ACUTE 34 0.0008
382 NEUROTOXICITY 14 0.0008
383 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
384 DEPRESSED MOOD 42 0.0008
385 KLEBSIELLA INFECTION 4 0.0008
386 PHOTOPSIA 5 0.0008
387 CARPAL TUNNEL SYNDROME 11 0.0008
388 PETIT MAL EPILEPSY 4 0.0008
389 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
390 DRUG DELIVERY SYSTEM MALFUNCTION 4 0.0008
391 ANAL INCONTINENCE 7 0.0008
392 TRISMUS 4 0.0008
393 LEUKOCYTOSIS 14 0.0008
394 CARDIAC FLUTTER 5 0.0008
395 PELVIC FRACTURE 6 0.0008
396 CONSTIPATION 168 0.0008
397 NERVOUS SYSTEM DISORDER 24 0.0008
398 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
399 PNEUMONIA BACTERIAL 7 0.0008
400 MEMORY IMPAIRMENT 104 0.0008
401 WRIST FRACTURE 9 0.0008
402 APPENDICITIS 7 0.0007
403 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
404 SOMNOLENCE 150 0.0007
405 CARDIOMYOPATHY 11 0.0007
406 MUSCLE TIGHTNESS 12 0.0007
407 AMNESIA 48 0.0007
408 CEREBRAL INFARCTION 18 0.0007
409 SLEEP APNOEA SYNDROME 14 0.0007
410 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
411 AFFECT LABILITY 7 0.0007
412 ATELECTASIS 7 0.0007
413 ABNORMAL DREAMS 20 0.0007
414 FOOT DEFORMITY 8 0.0007
415 PULMONARY HYPERTENSION 15 0.0007
416 CHOKING 14 0.0007
417 EXTRASYSTOLES 5 0.0007
418 BLINDNESS UNILATERAL 10 0.0007
419 STATUS EPILEPTICUS 8 0.0007
420 EJECTION FRACTION DECREASED 11 0.0007
421 DRUG INTERACTION 112 0.0007
422 IMPAIRED DRIVING ABILITY 8 0.0007
423 GENERALISED ERYTHEMA 4 0.0007
424 MYOCARDIAL ISCHAEMIA 8 0.0007
425 CHOLELITHIASIS 23 0.0007
426 MYOCARDITIS 8 0.0007
427 SKIN WARM 4 0.0007
428 SUBARACHNOID HAEMORRHAGE 7 0.0007
429 URINE OUTPUT DECREASED 6 0.0007
430 HYPOVOLAEMIA 4 0.0007
431 RESTLESSNESS 25 0.0007
432 MOUTH HAEMORRHAGE 5 0.0007
433 LUNG INFILTRATION 6 0.0007
434 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
435 POST PROCEDURAL COMPLICATION 13 0.0007
436 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
437 FEELING DRUNK 5 0.0007
438 FACIAL PAIN 6 0.0007
439 DEHYDRATION 89 0.0007
440 HYPOPHAGIA 17 0.0007
441 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
442 KIDNEY INFECTION 13 0.0007
443 TACHYPNOEA 9 0.0007
444 URINARY RETENTION 22 0.0007
445 NO THERAPEUTIC RESPONSE 8 0.0007
446 HIP FRACTURE 21 0.0007
447 DRUG ABUSER 4 0.0007
448 DRUG EFFECT DECREASED 35 0.0006
449 HEMIPARESIS 11 0.0006
450 THYROID DISORDER 10 0.0006
451 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
452 LOSS OF CONSCIOUSNESS 83 0.0006
453 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
454 THINKING ABNORMAL 12 0.0006
455 ILEUS 8 0.0006
456 HYPOTENSION 129 0.0006
457 BASAL CELL CARCINOMA 10 0.0006
458 STAPHYLOCOCCAL INFECTION 21 0.0006
459 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
460 OEDEMA PERIPHERAL 77 0.0006
461 HYPOAESTHESIA 94 0.0006
462 MYDRIASIS 8 0.0006
463 RHABDOMYOLYSIS 26 0.0006
464 SINUS BRADYCARDIA 6 0.0006
465 CHROMATURIA 14 0.0006
466 GASTROENTERITIS 9 0.0006
467 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
468 VITAMIN D DEFICIENCY 6 0.0006
469 JOINT INJURY 13 0.0006
470 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
471 DRUG LEVEL INCREASED 10 0.0006
472 COLON CANCER 9 0.0006
473 SKIN MASS 4 0.0006
474 BLOOD POTASSIUM DECREASED 18 0.0006
475 ATRIAL SEPTAL DEFECT 5 0.0006
476 INSOMNIA 159 0.0006
477 POST-TRAUMATIC STRESS DISORDER 4 0.0006
478 DRY MOUTH 48 0.0006
479 VERTIGO 36 0.0006
480 TOOTH ABSCESS 6 0.0006
481 CHOLECYSTITIS 7 0.0006
482 IMPAIRED GASTRIC EMPTYING 8 0.0006
483 AKATHISIA 8 0.0006
484 NEUTROPHIL COUNT INCREASED 6 0.0006
485 LYMPHOEDEMA 4 0.0006
486 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
487 SCHIZOPHRENIA 7 0.0006
488 LOWER LIMB FRACTURE 11 0.0006
489 VISUAL ACUITY REDUCED 19 0.0006
490 ASTHENIA 215 0.0006
491 GASTRITIS 15 0.0006
492 JOINT DISLOCATION 6 0.0006
493 NEPHROLITHIASIS 26 0.0006
494 IMMUNOSUPPRESSION 5 0.0006
495 CONDITION AGGRAVATED 172 0.0006
496 TYPE 2 DIABETES MELLITUS 19 0.0006
497 MUSCLE TWITCHING 13 0.0006
498 SINUS TACHYCARDIA 8 0.0006
499 RESPIRATORY RATE INCREASED 5 0.0006
500 DIVERTICULUM 4 0.0006
501 CORONARY ARTERY DISEASE 17 0.0006
502 POISONING 7 0.0006
503 HYPOGLYCAEMIA 27 0.0006
504 LETHARGY 32 0.0006
505 PHARYNGITIS STREPTOCOCCAL 6 0.0006
506 PULMONARY THROMBOSIS 6 0.0005
507 PATHOGEN RESISTANCE 5 0.0005
508 RESPIRATORY ARREST 15 0.0005
509 RESPIRATORY DISTRESS 15 0.0005
510 BLINDNESS TRANSIENT 4 0.0005
511 BLOOD PRESSURE DECREASED 36 0.0005
512 HIATUS HERNIA 7 0.0005
513 BODY TEMPERATURE INCREASED 11 0.0005
514 PRODUCT DISTRIBUTION ISSUE 5 0.0005
515 ABDOMINAL DISTENSION 56 0.0005
516 CELLULITIS 27 0.0005
517 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
518 ASPARTATE AMINOTRANSFERASE INCREASED 28 0.0005
519 AORTIC ANEURYSM 4 0.0005
520 TROPONIN INCREASED 4 0.0005
521 QUALITY OF LIFE DECREASED 7 0.0005
522 ALANINE AMINOTRANSFERASE INCREASED 32 0.0005
523 NIGHTMARE 18 0.0005
524 FEMUR FRACTURE 16 0.0005
525 DYSURIA 19 0.0005
526 LIVER FUNCTION TEST ABNORMAL 15 0.0005
527 PULMONARY EMBOLISM 49 0.0005
528 PERIPHERAL COLDNESS 7 0.0005
529 ANXIETY 145 0.0005
530 HEPATOMEGALY 5 0.0005
531 BODY TEMPERATURE DECREASED 5 0.0005
532 MENTAL DISORDER 22 0.0005
533 PRODUCT DOSE OMISSION 33 0.0005
534 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
535 MUSCLE SPASMS 92 0.0005
536 OVARIAN CYST 5 0.0005
537 EMPHYSEMA 5 0.0005
538 CRYING 18 0.0005
539 HYPERGLYCAEMIA 18 0.0005
540 FEEDING DISORDER 10 0.0005
541 BACK DISORDER 8 0.0005
542 INITIAL INSOMNIA 5 0.0005
543 SPINAL OPERATION 6 0.0005
544 ESCHERICHIA INFECTION 4 0.0005
545 CYST 6 0.0005
546 SYNCOPE 48 0.0005
547 PETECHIAE 5 0.0005
548 SHOCK 11 0.0005
549 WITHDRAWAL SYNDROME 20 0.0005
550 CEREBRAL HAEMORRHAGE 17 0.0005
551 FOOT FRACTURE 9 0.0005
552 MUSCLE ATROPHY 6 0.0005
553 NEUROPATHY PERIPHERAL 45 0.0005
554 DIABETES MELLITUS 36 0.0005
555 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
556 SLEEP DISORDER 33 0.0005
557 ERECTILE DYSFUNCTION 12 0.0005
558 SCAR 8 0.0005
559 HYPOAESTHESIA ORAL 7 0.0005
560 CARDIAC MURMUR 4 0.0005
561 SKIN SWELLING 4 0.0005
562 BIPOLAR DISORDER 5 0.0005
563 BACK INJURY 5 0.0005
564 TOXICITY TO VARIOUS AGENTS 77 0.0005
565 HEPATIC FUNCTION ABNORMAL 17 0.0005
566 PULMONARY CONGESTION 6 0.0005
567 EMOTIONAL DISORDER 14 0.0005
568 MENTAL IMPAIRMENT 11 0.0005
569 LIMB DISCOMFORT 14 0.0005
570 RENAL IMPAIRMENT 38 0.0005
571 DENTAL CARIES 5 0.0005
572 JAUNDICE 12 0.0004
573 CYANOSIS 7 0.0004
574 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
575 HYPONATRAEMIA 25 0.0004
576 OPTIC NEURITIS 4 0.0004
577 TACHYCARDIA 39 0.0004
578 EXOSTOSIS 4 0.0004
579 OSTEOPOROSIS 18 0.0004
580 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
581 SUICIDAL IDEATION 40 0.0004
582 RETINAL DETACHMENT 4 0.0004
583 OVARIAN CANCER 4 0.0004
584 INTERSTITIAL LUNG DISEASE 21 0.0004
585 NERVE COMPRESSION 4 0.0004
586 COMPLETED SUICIDE 36 0.0004
587 DIZZINESS 215 0.0004
588 PERSONALITY CHANGE 4 0.0004
589 INTENTIONAL DRUG MISUSE 9 0.0004
590 CHEST DISCOMFORT 44 0.0004
591 HEPATIC STEATOSIS 8 0.0004
592 MIDDLE INSOMNIA 8 0.0004
593 DEFORMITY 4 0.0004
594 VISUAL IMPAIRMENT 53 0.0004
595 SPLENOMEGALY 5 0.0004
596 FLANK PAIN 4 0.0004
597 SEXUAL DYSFUNCTION 5 0.0004
598 SKIN ULCER 11 0.0004
599 RESPIRATORY FAILURE 31 0.0004
600 ARTERIOSCLEROSIS 4 0.0004
601 LYMPHOPENIA 6 0.0004
602 PAIN IN JAW 12 0.0004
603 FRACTURE 8 0.0004
604 BLOOD IRON DECREASED 5 0.0004
605 IRRITABLE BOWEL SYNDROME 9 0.0004
606 POOR QUALITY SLEEP 9 0.0004
607 DIABETIC KETOACIDOSIS 10 0.0004
608 HYPERTENSION 88 0.0004
609 BLOOD CREATININE INCREASED 27 0.0004
610 SKIN DISCOLOURATION 19 0.0004
611 PRESCRIBED OVERDOSE 8 0.0004
612 RESPIRATORY DEPRESSION 5 0.0004
613 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
614 ACUTE MYOCARDIAL INFARCTION 12 0.0004
615 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
616 FATIGUE 316 0.0004
617 LIMB INJURY 11 0.0004
618 LIGAMENT SPRAIN 4 0.0004
619 HYPERHIDROSIS 52 0.0004
620 INFLUENZA 45 0.0004
621 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
622 PARAESTHESIA 63 0.0004
623 RASH MACULAR 14 0.0004
624 HYPERKALAEMIA 14 0.0004
625 HYPOXIA 14 0.0004
626 COLD SWEAT 7 0.0004
627 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
628 PERIPHERAL SWELLING 61 0.0004
629 OSTEOPENIA 6 0.0004
630 PNEUMONIA 128 0.0004
631 HYPOTHERMIA 4 0.0004
632 INJECTION SITE IRRITATION 5 0.0004
633 BLINDNESS 16 0.0004
634 EPILEPSY 12 0.0004
635 BRONCHITIS 29 0.0004
636 HYPOKALAEMIA 18 0.0004
637 ROTATOR CUFF SYNDROME 5 0.0004
638 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
639 GASTROENTERITIS VIRAL 7 0.0004
640 RASH GENERALISED 10 0.0004
641 INJECTION SITE INDURATION 5 0.0004
642 PANIC ATTACK 14 0.0004
643 INJURY 27 0.0004
644 MYOCARDIAL INFARCTION 67 0.0004
645 NODULE 5 0.0004
646 BRAIN FOG 6 0.0004
647 CARDIO-RESPIRATORY ARREST 16 0.0004
648 ROAD TRAFFIC ACCIDENT 16 0.0004
649 KNEE ARTHROPLASTY 8 0.0004
650 PULMONARY OEDEMA 17 0.0004
651 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
652 TOOTH INFECTION 5 0.0004
653 COMA 18 0.0004
654 SOPOR 5 0.0004
655 DYSMENORRHOEA 5 0.0004
656 SCIATICA 6 0.0004
657 BODY HEIGHT DECREASED 4 0.0004
658 JOINT RANGE OF MOTION DECREASED 5 0.0004
659 BREAST CANCER METASTATIC 4 0.0004
660 HOT FLUSH 28 0.0004
661 DECREASED ACTIVITY 4 0.0004
662 DECREASED APPETITE 86 0.0004
663 HEART RATE DECREASED 13 0.0004
664 IMPAIRED HEALING 12 0.0004
665 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
666 HEPATIC FAILURE 11 0.0004
667 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
668 CONTUSION 35 0.0004
669 MELAENA 8 0.0004
670 EMOTIONAL DISTRESS 44 0.0004
671 WEIGHT DECREASED 101 0.0004
672 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
673 VIRAL INFECTION 12 0.0004
674 ARRHYTHMIA 17 0.0004
675 HUNGER 5 0.0004
676 FEELING HOT 22 0.0004
677 HAEMORRHOIDS 7 0.0004
678 NECK PAIN 20 0.0004
679 MENORRHAGIA 7 0.0004
680 REBOUND EFFECT 4 0.0004
681 DRUG WITHDRAWAL SYNDROME 31 0.0004
682 SEASONAL ALLERGY 5 0.0004
683 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
684 PRODUCT AVAILABILITY ISSUE 8 0.0004
685 UPPER LIMB FRACTURE 7 0.0004
686 CARDIAC ARREST 29 0.0004
687 CHEST PAIN 65 0.0004
688 BRONCHOSPASM 5 0.0004
689 SEPSIS 39 0.0003
690 SPINAL FRACTURE 7 0.0003
691 ANGINA PECTORIS 10 0.0003
692 MUSCULOSKELETAL DISCOMFORT 6 0.0003
693 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
694 GASTRIC HAEMORRHAGE 4 0.0003
695 DYSPNOEA EXERTIONAL 13 0.0003
696 SEPTIC SHOCK 15 0.0003
697 ELECTROLYTE IMBALANCE 4 0.0003
698 CEREBROVASCULAR ACCIDENT 58 0.0003
699 SEIZURE 39 0.0003
700 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
701 SKIN HAEMORRHAGE 5 0.0003
702 IMMUNODEFICIENCY 5 0.0003
703 DYSPEPSIA 33 0.0003
704 VISION BLURRED 46 0.0003
705 RESPIRATORY DISORDER 10 0.0003
706 POLYNEUROPATHY 4 0.0003
707 OSTEOMYELITIS 6 0.0003
708 BLOOD COUNT ABNORMAL 5 0.0003
709 BURSITIS 4 0.0003
710 TREATMENT NONCOMPLIANCE 18 0.0003
711 RETCHING 7 0.0003
712 DRUG DISPENSING ERROR 5 0.0003
713 SKIN CANCER 7 0.0003
714 PHARYNGEAL OEDEMA 5 0.0003
715 SMALL INTESTINAL OBSTRUCTION 4 0.0003
716 INJECTION SITE MASS 12 0.0003
717 CARDIAC FAILURE 26 0.0003
718 DEEP VEIN THROMBOSIS 21 0.0003
719 BLOOD CHOLESTEROL INCREASED 15 0.0003
720 HAEMATURIA 11 0.0003
721 BRADYCARDIA 17 0.0003
722 BLOOD SODIUM DECREASED 6 0.0003
723 FEELING ABNORMAL 76 0.0003
724 MUSCULOSKELETAL DISORDER 6 0.0003
725 CARDIOVASCULAR DISORDER 8 0.0003
726 RED BLOOD CELL COUNT DECREASED 9 0.0003
727 MIGRAINE 30 0.0003
728 PULMONARY FIBROSIS 6 0.0003
729 RASH PAPULAR 7 0.0003
730 ANOREXIA 4 0.0003
731 BACK PAIN 72 0.0003
732 EAR PAIN 6 0.0003
733 APPLICATION SITE PRURITUS 7 0.0003
734 HEPATIC ENZYME INCREASED 21 0.0003
735 NERVOUSNESS 16 0.0003
736 SEDATION 8 0.0003
737 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
738 EYE DISORDER 10 0.0003
739 ORAL CANDIDIASIS 4 0.0003
740 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
741 SARS-COV-2 TEST POSITIVE 4 0.0003
742 PHOTOSENSITIVITY REACTION 5 0.0003
743 PANCREATITIS 16 0.0003
744 DRUG INTOLERANCE 29 0.0003
745 EYE HAEMORRHAGE 4 0.0003
746 CARDIAC FAILURE CONGESTIVE 24 0.0003
747 MALIGNANT MELANOMA 4 0.0003
748 THROMBOSIS 24 0.0003
749 ATRIAL FIBRILLATION 29 0.0003
750 SUICIDE ATTEMPT 18 0.0003
751 PYREXIA 102 0.0003
752 ARTHRITIS 23 0.0003
753 THERAPY CESSATION 15 0.0003
754 PAIN IN EXTREMITY 86 0.0003
755 BLOOD PRESSURE FLUCTUATION 7 0.0003
756 CHILLS 34 0.0003
757 LOCALISED INFECTION 7 0.0003
758 MULTI-ORGAN FAILURE 5 0.0003
759 DIVERTICULITIS 8 0.0003
760 ANAEMIA 55 0.0003
761 SWOLLEN TONGUE 9 0.0003
762 ORAL DISCOMFORT 4 0.0003
763 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
764 LIVER INJURY 7 0.0003
765 DEVICE OCCLUSION 4 0.0003
766 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
767 IRRITABILITY 17 0.0003
768 HAEMOGLOBIN DECREASED 29 0.0003
769 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
770 PLEURAL EFFUSION 17 0.0003
771 PRODUCT DISPENSING ERROR 6 0.0003
772 C-REACTIVE PROTEIN INCREASED 10 0.0003
773 BONE DISORDER 5 0.0003
774 INJECTION SITE ERYTHEMA 34 0.0003
775 HEPATITIS 7 0.0003
776 JOINT SWELLING 33 0.0003
777 HEART RATE INCREASED 27 0.0003
778 ANAPHYLACTIC REACTION 15 0.0003
779 RENAL FAILURE 36 0.0003
780 BURNING SENSATION 19 0.0003
781 HAEMATOMA 7 0.0003
782 TOOTH DISORDER 6 0.0003
783 RESPIRATORY TRACT INFECTION 7 0.0003
784 PRODUCT DOSE OMISSION ISSUE 79 0.0003
785 GLOSSODYNIA 6 0.0003
786 DEVICE ISSUE 24 0.0003
787 HAEMORRHAGE INTRACRANIAL 4 0.0003
788 APPLICATION SITE ERYTHEMA 7 0.0003
789 ANHEDONIA 7 0.0003
790 PHOTOPHOBIA 5 0.0003
791 HEART RATE IRREGULAR 6 0.0003
792 FLATULENCE 15 0.0003
793 UNEVALUABLE EVENT 20 0.0003
794 DRY EYE 13 0.0003
795 UNDERDOSE 19 0.0003
796 PERICARDIAL EFFUSION 6 0.0003
797 TENDONITIS 4 0.0003
798 OEDEMA 14 0.0003
799 RENAL DISORDER 12 0.0003
800 PALLOR 7 0.0003
801 HEADACHE 161 0.0003
802 GASTROINTESTINAL DISORDER 23 0.0003
803 THERAPY PARTIAL RESPONDER 4 0.0003
804 DYSPNOEA 145 0.0003
805 INFECTION 37 0.0003
806 SKIN LESION 7 0.0003
807 BLOOD PRESSURE INCREASED 39 0.0003
808 DEVICE DISLOCATION 11 0.0003
809 ABDOMINAL PAIN UPPER 52 0.0003
810 SINUS DISORDER 5 0.0003
811 PAIN 155 0.0003
812 PNEUMOTHORAX 4 0.0003
813 OBESITY 4 0.0003
814 MOOD SWINGS 8 0.0003
815 ABSCESS 4 0.0003
816 HYPOTHYROIDISM 8 0.0003
817 WOUND 7 0.0003
818 METABOLIC ACIDOSIS 8 0.0002
819 NIGHT SWEATS 8 0.0002
820 LIVER DISORDER 11 0.0002
821 CARDIAC DISORDER 23 0.0002
822 INTENTIONAL DOSE OMISSION 7 0.0002
823 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
824 TOOTH LOSS 5 0.0002
825 RASH PRURITIC 13 0.0002
826 INTESTINAL OBSTRUCTION 9 0.0002
827 COLITIS 9 0.0002
828 ABDOMINAL PAIN LOWER 6 0.0002
829 WEIGHT INCREASED 53 0.0002
830 ANGER 8 0.0002
831 VOMITING 111 0.0002
832 WHEEZING 14 0.0002
833 OSTEOARTHRITIS 10 0.0002
834 CIRCULATORY COLLAPSE 4 0.0002
835 ALOPECIA 46 0.0002
836 IMPAIRED WORK ABILITY 5 0.0002
837 MEDICATION ERROR 13 0.0002
838 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
839 GASTRIC DISORDER 8 0.0002
840 MALAISE 102 0.0002
841 NAUSEA 184 0.0002
842 HYPOACUSIS 10 0.0002
843 ABDOMINAL PAIN 54 0.0002
844 DISEASE RECURRENCE 11 0.0002
845 PRURITUS GENERALISED 5 0.0002
846 ILL-DEFINED DISORDER 14 0.0002
847 LOCAL SWELLING 4 0.0002
848 DEVICE USE ISSUE 4 0.0002
849 NASOPHARYNGITIS 42 0.0002
850 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
851 ABDOMINAL DISCOMFORT 38 0.0002
852 HERPES ZOSTER 13 0.0002
853 DRUG ERUPTION 4 0.0002
854 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
855 SINUSITIS 23 0.0002
856 GALLBLADDER DISORDER 4 0.0002
857 THIRST 4 0.0002
858 MYALGIA 38 0.0002
859 BLOOD BILIRUBIN INCREASED 6 0.0002
860 PNEUMONITIS 6 0.0002
861 MOOD ALTERED 6 0.0002
862 DISEASE PROGRESSION 26 0.0002
863 FLUID RETENTION 11 0.0002
864 LACTIC ACIDOSIS 7 0.0002
865 HAEMOPTYSIS 6 0.0002
866 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
867 OVERDOSE 46 0.0002
868 ADVERSE DRUG REACTION 19 0.0002
869 BLOOD URINE PRESENT 4 0.0002
870 RECTAL HAEMORRHAGE 9 0.0002
871 FIBROMYALGIA 5 0.0002
872 COVID-19 36 0.0002
873 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
874 HYPERSENSITIVITY 38 0.0002
875 ASCITES 6 0.0002
876 DRUG INEFFECTIVE 268 0.0002
877 ACUTE KIDNEY INJURY 31 0.0002
878 DISABILITY 4 0.0002
879 LEUKOPENIA 10 0.0002
880 PREGNANCY 4 0.0002
881 HAEMATEMESIS 5 0.0002
882 TINNITUS 9 0.0002
883 DRUG ADMINISTRATION ERROR 6 0.0002
884 EYE PAIN 11 0.0002
885 INJECTION SITE WARMTH 4 0.0002
886 PERITONITIS 4 0.0002
887 ACCIDENTAL OVERDOSE 7 0.0002
888 MUSCULOSKELETAL PAIN 10 0.0002
889 JOINT STIFFNESS 5 0.0002
890 MOUTH ULCERATION 4 0.0002
891 DIARRHOEA 122 0.0002
892 PALPITATIONS 22 0.0002
893 DRUG DOSE OMISSION 31 0.0002
894 ASTHMA 21 0.0002
895 RHINORRHOEA 12 0.0002
896 ERYTHEMA 38 0.0002
897 THROAT TIGHTNESS 5 0.0002
898 FAECES DISCOLOURED 4 0.0002
899 OFF LABEL USE 161 0.0002
900 COUGH 51 0.0002
901 ARTHRALGIA 75 0.0002
902 STEVENS-JOHNSON SYNDROME 4 0.0002
903 RASH MACULO-PAPULAR 4 0.0002
904 ORAL PAIN 4 0.0002
905 INJECTION SITE REACTION 12 0.0002
906 EXTRA DOSE ADMINISTERED 7 0.0002
907 INTENTIONAL PRODUCT MISUSE 15 0.0002
908 LYMPHADENOPATHY 6 0.0002
909 SWELLING FACE 11 0.0002
910 DRUG ABUSE 14 0.0002
911 CATARACT 10 0.0002
912 PRODUCTIVE COUGH 8 0.0002
913 RASH ERYTHEMATOUS 8 0.0002
914 DEATH 144 0.0002
915 BLOOD GLUCOSE DECREASED 8 0.0002
916 THERAPEUTIC RESPONSE DECREASED 10 0.0002
917 BLOOD GLUCOSE INCREASED 31 0.0002
918 LUNG DISORDER 8 0.0002
919 HAEMORRHAGE 17 0.0002
920 ARTHROPATHY 9 0.0002
921 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
922 SWELLING 15 0.0002
923 INTENTIONAL OVERDOSE 10 0.0002
924 INFLAMMATION 8 0.0002
925 BONE PAIN 9 0.0002
926 PRURITUS 59 0.0002
927 PRODUCT USE IN UNAPPROVED INDICATION 38 0.0002
928 OSTEONECROSIS 5 0.0002
929 INJECTION SITE BRUISING 12 0.0002
930 EAR INFECTION 4 0.0002
931 SKIN DISORDER 5 0.0001
932 NEOPLASM MALIGNANT 10 0.0001
933 MENSTRUATION IRREGULAR 4 0.0001
934 DEVICE BREAKAGE 6 0.0001
935 DISCOMFORT 9 0.0001
936 OCULAR HYPERAEMIA 7 0.0001
937 LUNG NEOPLASM MALIGNANT 6 0.0001
938 HAEMATOCHEZIA 8 0.0001
939 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
940 INJECTION SITE PAIN 43 0.0001
941 RASH 61 0.0001
942 LABORATORY TEST ABNORMAL 4 0.0001
943 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
944 SKIN EXFOLIATION 11 0.0001
945 HOSPITALISATION 20 0.0001
946 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
947 PANCYTOPENIA 7 0.0001
948 THROMBOCYTOPENIA 14 0.0001
949 ABORTION SPONTANEOUS 5 0.0001
950 BLISTER 7 0.0001
951 PLATELET COUNT DECREASED 13 0.0001
952 EPISTAXIS 9 0.0001
953 LIP SWELLING 4 0.0001
954 FUNGAL INFECTION 4 0.0001
955 SURGERY 7 0.0001
956 URTICARIA 20 0.0001
957 INJECTION SITE SWELLING 9 0.0001
958 STOMATITIS 7 0.0001
959 ECZEMA 6 0.0001
960 INCORRECT DOSE ADMINISTERED 26 0.0001
961 THERAPY INTERRUPTED 8 0.0001
962 THROAT IRRITATION 5 0.0001
963 PRODUCT QUALITY ISSUE 15 0.0001
964 DRUG EFFECT INCOMPLETE 4 0.0001
965 OXYGEN SATURATION DECREASED 6 0.0001
966 DRY SKIN 14 0.0001
967 INJECTION SITE HAEMORRHAGE 8 0.0001
968 OROPHARYNGEAL PAIN 9 0.0001
969 TREATMENT FAILURE 8 0.0001
970 DYSGEUSIA 7 0.0001
971 INJECTION SITE PRURITUS 6 0.0001
972 THERAPY NON-RESPONDER 4 0.0001
973 NO ADVERSE EVENT 16 0.0001
974 NASAL CONGESTION 5 0.0001
975 DRUG DEPENDENCE 13 0.0001
976 PRODUCT USE ISSUE 15 0.0001
977 ILLNESS 8 0.0001
978 ADVERSE EVENT 7 0.0001
979 BREAST CANCER 7 0.0001
980 SKIN BURNING SENSATION 5 0.0001
981 EYE IRRITATION 4 0.0001
982 PRODUCT SUBSTITUTION ISSUE 4 0.0001
983 PROSTATE CANCER 5 0.0001
984 FEBRILE NEUTROPENIA 4 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
986 PRODUCT STORAGE ERROR 5 0.0001
987 DEVICE MALFUNCTION 4 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
990 PSORIASIS 6 0.0000
991 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
993 NEUTROPENIA 5 0.0000
994 RHEUMATOID ARTHRITIS 4 0.0000